https://www.selleckchem.com/pr....oducts/2-aminoethane
both the center and interaction effects were eliminated ( 0.05). There was no significant difference in the incidence of adverse events between the two groups, and no serious adverse event was noted during the observation. Compared with placebo, BLWTG markedly improved EPS in FD patients without causing serious adverse reactions. Compared with placebo, BLWTG markedly improved EPS in FD patients without causing serious adverse reactions. Children with esophageal atresia (EA) have risk of gastroesophageal reflux disease (G
Like
Comment
Share
